Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review

Published:2020-10-06 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Wang Mingxing,Xu Yunyun,Yang Min,Jiang Dingyi,Chen Yunwang,Jiang Jiahong,Chen Zheling,Yang Liu,Huang Dongsheng

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. [Metastatic ability occurs already early on in pancreatic cancer];Andersson;Lakartidningen,2017

2. Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded favorably to nonsurgical treatment;Asano;J. Hepatobiliary Pancreat. Sci.,2018

3. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ducreux;Ann. Oncol.,2015

4. Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive;Fong;Cancer J. (Sudbury Mass.),2012

5. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery;Frigerio;Ann. Surg. Oncol.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma;Investigational New Drugs;2022-07-06

2. Ursolic acid inhibits the activation of smoothened‐independent non‐canonical hedgehog pathway in colorectal cancer by suppressing AKT signaling cascade;Phytotherapy Research;2022-06-16

3. New Insights into LINC00346 and its Role in Disease;Frontiers in Cell and Developmental Biology;2022-01-13

4. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models;Advanced Drug Delivery Reviews;2021-07

5. Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid;Cancers;2021-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3